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Background: This research comprised a laboratory evaluation of a novel refractive surgery 
technique involving sequential corneal subsurface shrinkage-driven reshaping using a continu-
ous wave mid-infrared laser application followed by stiffening via rapid transepithelial higher 
fluence collagen cross-linking for shape persistence/longevity on cadaver corneas.
Materials and methods: Ten cadaver corneas were used in this study. During use, all were 
affixed in an artificial chamber. Thermal delivery entailed a continuous wave laser at 2013 nm 
wavelength, approximately 650 mW power under scanner control (about 3 mm/sec linear draw 
speed), with a planoconcave sapphire applanation lens cooled to 8°C. Group 1 (n = 5, myopic 
treatment) eyes were exposed to three concentric annuli with diameters of 3 mm, 4 mm, and 
5 mm. Group 2 (n = 5, hyperopic treatment) eyes were exposed to three concentric annuli with 
diameters of 6 mm, 7 mm, and 8 mm. The clinical change in shape of the cornea was visualized 
immediately under a slit-lamp. A transepithelial higher fluence corneal collagen cross-linking step 
followed each thermal treatment, comprising 0.1% riboflavin drops with 0.02% benzalkonium 
chloride and 0.2% carboxymethlycellulose in deuterated water (D2O) applied on the epithelium 
corneal surface for 10 minutes. Next, each cornea was exposed to 10 mW/cm2 of ultraviolet A 
(365 nm) light for 10 minutes. The corneas were evaluated before and after thermal remodeling 
and cornea collagen cross-linking for corneal topography, corneal optical coherence tomography, 
cornea Scheimpflug tomography, and clinical photographs.
Results: The histopathology effect was noted clinically as concentric white rings underneath 
the epithelium and Bowman’s membrane, with the lesion depth extending down to 400 µm in 
the mid stroma of the cornea. This was confirmed by corneal anterior segment optical coherence 
tomography. The topographic change noted was a 4–8 diopter hyperopic shift in group 1 and 
a 2–6 diopter myopic shift in group 2.
Conclusion: This novel refractive surgery technique appears to generate a significant refrac-
tive change (+/-) in the cornea, without affecting the epithelium or Bowman’s membrane and 
without any visible epithelial defect. The transepithelial collagen cross-linking used as a second 
step in the same procedure aims to stabilize this effect in the long term. Further clinical studies 
are planned to validate these initial clinical results.
Keywords: cornea collagen shrinkage, refractive cornea change, cornea collagen cross-linking, 
infrared laser
Introduction
Historical attempts at reshaping corneal collagen, such as conductive keratoplasty and 
laser thermal keratoplasty, in order to achieve a refractive change, have been studied 
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extensively in ophthalmology.1–14 A particular attraction of 
these procedures has been the nonablative tissue-sparing 
reshaping result, while a common concern has been stability/
regression of effect, hence long-term predictability. Recently, 
the Keraflex® two-step procedure (Avedro, Waltham, MA) 
has been reported to utilize a contact probe which deposits 
microwave thermal energy onto the anterior cornea, induc-
ing collagen shrinkage.14–18 A circular epithelial defect has 
been noted immediately postoperatively. This thermal step 
is sequenced by lesional collagen cross-linking in order to 
establish longevity of the corneal remodeling achieved by 
the thermal effect of this procedure.
We report herein a novel in situ thermal reshaping 
application in which a continuous wave infrared laser is 
used to create selective collagen shrinkage in the anterior 
to mid stroma, without affecting the corneal epithelium or 
Bowman’s membrane or endothelium, then applying high 
irradiance ultraviolet light with a customized riboflavin 
formulation for collagen cross-linking to stiffen collagen for 
persistence of this refractive effect in a laboratory model.
Materials and methods
Ten cadaver eyes, provided by the Eye-Bank for Sight 
Restoration (New York, NY) were utilized on a single-use 
artificial chamber (Katena, Denville, NJ). The corneas were 
carefully handled so as to not disturb their epithelium, with 
instillations of Vidilac preserved artificial tears (Bausch and 
Lomb Dublin, Ireland, see Figures 1 and 2). The corneas 
Figure 1 Preparation of the donor cornea from the storage vial (Optisol® solution; 
Oxonica, haddenham, UK) onto the Katena® artificial anterior chamber (Katena 
Products, Inc, Denville, NJ).
Figure 2 Donor cornea is fixated in the artificial anterior chamber and pressurized 
to 30 mmhg to mimic in vivo physiology and reduce edema.
Figure 3 Fixated donor cornea scanned with Optovue cornea optical coherence 
tomography (Optuvue, Inc, Freemont, CA).
were imaged before and after treatment with corneal optical 
coherence tomography (Optovue, Freemont, CA, Figure 3), 
Placido disc corneal topography (Topolyzer; Wavelight, 
Erlagen, Germany) and a Scheimpflug cornea tomography 
device (Oculyzer; Wavelight; Figure 4) were used in order 
to establish baseline corneal parameters, ie, texture and 
anatomy, as well as cornea curvature and refractive power. 
Next, the corneas were placed under the prototype continuous 
wave infrared laser device articulating arm.
The novel infrared laser device consisted of a mid infrared 
2013 nm laser-generating element coupled to a PC-controlled 
scanner (Figure 5) via a fiber and focused onto the cornea 
through an applanated chilled sapphire lens housed in a 
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speed, and power control, significant precision of outcomes 
(diopters of correction) was provided by the device.
Following an applanated cooling period of 30 seconds, 
the treatment was started under the control of a foot switch. 
It should be noted that key parameters of the laser application 
were specified by the surgeon at the start of each exposure. 
The surgeon could select one, two, three, or up to seven ring 
Figure 4 Fixated donor cornea scanned with Oculyzer (Pentacam) Scheimpflug 
cornea tomography (Wavelight).
Figure 5 Computer screen of the novel treatment device. On the left of the screen, 
the user can visualize the planned concentric ring treatment. All parameters of these 
rings are customizable (diameter, spacing, number, centration, and arc). On the right 
of the screen, the applanated cornea and its centration is visualized.
cone assembly on the articulating arm (Figures 6 and 7). 
The sapphire lens was cooled to about 8°C. The laser device 
was lowered to applanate the cornea (Figure 8), and this was 
directly visualized by the operator through the superior open-
ing of the cone (Figure 9), and also on the PC output from 
the camera. Each cadaver cornea was marked in the center 
with a permanent marker, and this mark was used during 
the experimental treatment as the pupil center analog for 
centration.
Ring diameters and the sequence of patterns with speed 
and power were settable on the PC screen by the surgeon. Due 
to such extensive flexibility in laser depth, diameter, draw 
Figure 6 Cornea interface cone that comes into contact with the cornea to be 
treated with a cooled sapphire crystal interface.
Figure 7 Different angle of the same interface seen in Figure 6.
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applications in sequence. These rings can be placed anywhere 
on the applanated surface of the cornea (including selectively 
and precisely decentered), and visualized on the computer 
screen. Intraring distance was set as per the   surgeon’s 
  preference. Based on preliminary unpublished work that 
we have done with this device for correction of myopia, 
we decided to place the three lesional rings at diameters of 
3 mm, 4 mm and 5 mm, each planned to focus laser treatment 
at a depth of 100 µm and centered on the cornea.
The device was activated by a foot switch, and each 
ring was created through a continuous wave laser, applying 
the laser energy in a circular counterclockwise fashion, to 
create a complete circular subsurface ring lesion. First, the 
3 mm diameter ring was completed, then the 4 mm diameter 
ring, and finally the 5 mm diameter ring. The total laser 
application per ring lasts about 4 seconds, and complete 
applanation of the arm on the cornea lasted under one 
minute (30 seconds + 12 seconds + 15 seconds). The system 
is designed to provide constant but selectable linear draw 
speeds at each diameter, thus inducing a uniform quality 
of lesion.
Following infrared laser delivery, cooling was continued 
for a further 15 seconds. Next, the applanation device was 
disengaged from the cornea. The cornea was then evaluated 
under the slit-lamp, and slit-lamp photographs were taken. 
The clinical effect of laser treatment was clearly evident 
as white opaque circular rings within the corneal stroma. 
There was no epithelial defect noted on the cornea surface, 
and corneal shrinkage noted on the slit-lamp was evaluated 
to be at about half the cornea depth. This was then further 
evaluated by corneal optical coherence tomography and 
corneal Placido disc-based topography and Scheimpflug 
tomographic mapping.
The hyperopic treatment was very similar to the myo-
pic treatment described earlier, with the difference being 
that the concentric rings were applied at 6 mm, 7 mm, and 
8 mm diameters from the center of the applanated cornea. 
On completion of laser application, the corneas were placed 
in a proprietary 0.1% riboflavin solution for half an hour, and 
then exposed to 10 mW/cm2 ultraviolet light for 10 minutes 
to obtain corneal collagen cross-linking.
Results
Five corneas subjected to myopic treatment showed a very 
similar slit-lamp and corneal optical coherence tomography 
effect. Corneal shrinkage was achieved, starting at about 
100 µm in depth and extending down to about 300 µm in 
depth, with an annulus thickness of about 800 µm. There was 
no change in the corneal epithelium, while corneal topography 
showed flattening of the cornea (Figure 10, treated cornea 
does not stain with fluorescein), creating a hyperopic shift, 
which ranged from 4 to 8 diopters with a mean change of 6.5 
diopters (Figure 11, corneal optical coherence tomography 
Figure 8 Interface is engaged onto the cornea to be treated. The stainless steel ring 
above the sapphire crystal appears to be condensing moisture, an indication of the 
cooling effect of the sapphire crystal.
Figure  9  Operator’s  view  of  the  applanated  cornea  through  the  laser  device, 
establishing proper centration.
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Figure 10 A laser-treated cornea, stained with fluorescein dye, shows no signs of 
epithelial injury.
Figure 11 Optical coherence tomography image of a laser-treated cornea, showing 
three dense mid-anterior stromal lesions, and no epithelial disturbance.
showing corneal shrinkage as a dense hyper-reflective spot). 
Figures 12 and 13 show representative myopic treatment 
(pre, post, and difference). 
Similar results were found in the hyperopic group, in 
which the myopic shift (steepening) of the central cornea was 
found to be 2–6 diopters, with an average diopter change of 
4.2 in the central cornea. Figure 14 shows a representative 
hyperopic treatment (pre-, post-, and difference). Clinical 
pictures of the corneas following treatment are shown in 
Figure 15.
Discussion
We hypothesize that quality of vision outcome is related 
to quality of the lesion, including its position and size 
  characteristics within the three-dimensional stromal collagen 
matrix. We have seen that shrinkage from thermal lesions 
at a programmable diameter/depth can be titrated to control 
the changes in the shape of the corneal surface that persist 
  following cross-linking. This epithelium-sparing,   reshaping, 
and stabilizing technique is clearly a novel approach in 
  refractive manipulation of the cornea. Our small laboratory 
study shows a remarkable refractive change immediately after 
delivery that was relatively consistent in all the corneas.
An interesting finding was the fact that laser application 
did not affect the corneal epithelium or in most cases the 
Bowman’s membrane at all. The actual location of the ring 
lesion was very close to the planned dimensions. There was 
no abrasion or thermal effect on the corneal epithelium and 
thus the nerve plexus was likely to have been preserved. 
Laser application appeared to cause collagen shrinkage that 
could be constrained (“endothelium-sparing”) as needed to 
a corneal depth of approximately 50%. This was confirmed 
on evaluation of the cornea after the procedure, as well as 
by corneal optical coherence tomography.
We also used transepithelial higher fluence corneal 
collagen cross-linking in order to help maintain an intact 
epithelium, which is the unique aspect of this procedure. 
Although transepithelial corneal collagen cross-linking may 
potentially affect epithelial cell viability, it is nevertheless 
not associated with an obvious clinical epithelial defect. We 
have previously reported the clinical safety and efficacy of 
higher fluence corneal collagen cross-linking for progressive 
keratoconus.19 Transepithelial corneal collagen cross-linking 
has been described previously as a treatment for progressive 
cornea ectasia.20 We used transepithelial corneal collagen 
cross-linking as a means of stabilizing the refractive effect 
of corneal shrinkage, as described elsewhere.8 In order to 
perform the transepithelial corneal collagen cross-linking, we 
used 0.1% riboflavin sodium phosphate drops containing ben-
zalkonium chloride. The purpose of these drops was to loosen 
the hemidesmosome links between the epithelial cells of the 
cornea and to allow the large riboflavin molecule to sink into 
the corneal stroma and achieve collagen cross-linking.
The purpose of sequencing collagen cross-linking in the 
thermal procedure is to enhance persistence of the collagen 
shrinkage effect from continuous wave laser application. 
This procedure has several advantages. One is the ability to 
titrate the amount of refractive change (+/-) applied to the 
cornea via number and diameter of the thermal rings applied. 
Another advantage is that the delivery can be “free form”, 
i.e. these rings can be moved on the applanated surface of 
the cornea and potentially be centered over any ectatic part 
of the cornea, and shrink that part of the cornea and flatten 
the ectasia. “Bow tie” patterns for astigmatic corrections, 
reported elsewhere, are easily feasible.
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Figures 12 and 13 Both these images illustrate the pre- (center) and post- (right) laser treatment corneal topography, as well as the difference (left). The significant central 
and homogenous hyperopic shift confirms that myopic treatment has been achieved.
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Figure 14 Pre- (left) and post- (middle) laser treatment Scheimflug-generated tomography image (Oculyzer/Pentacam; Wavelight), along with the difference map (right). 
Significant myopic shift is evident, depicting the symmetric and homogenous refractive corneal shape change.
Figure 15 External view of a treated cornea prior to riboflavin administration and 
corneal collagen cross-linking, showing again the intact epithelial surface.
We have introduced and evaluated clinically the use of 
topography-guided excimer laser normalization techniques 
combined with corneal collagen cross-linking, i.e. the   Athens 
protocol, in the treatment of corneal ectasia associated with 
keratoconus, iatrogenic ectasia, and recently severe cornea 
scarring.21–27 The novel treatment described herein may 
become an alternative to the Athens protocol, serving poten-
tially the same purpose of normalizing corneal irregularity 
with customized toric and spherical infrared laser cornea 
refractive modification and stabilizing the ectasia with 
combined corneal collagen cross-linking, without tissue 
removal or corneal thinning.
Although not studied herein, the pachymetry require-
ments of such a treatment may be as low as 350 µm in vivo, 
allowing its application in extreme ectasia. The main differ-
ence between this technique and the Keraflex is in essence 
the lack of epithelial injury and highly titratable nature of the 
laser application and therefore corneal shrinkage.
Conclusion
This novel laser and corneal collagen cross-linking treatment 
appears to be able to both flatten and steepen the cornea, 
depending on the diameter and depth of laser application, 
and coupled with transepithelial collagen cross-linking, may 
provide a novel nonincisional, nonimplanted, sutureless, and 
essentially pain-free procedure (due to no epithelium defect). 
Very little discomfort is anticipated in real clinical use postop-
eratively, and there is a very low risk of infectious complica-
tions involving the cornea. Further clinical studies are needed 
to validate these findings in clinical practice and potentially 
make this novel procedure a valid alternative for the   correction 
of myopia, hyperopia, astigmatism, and presbyopia, and poten-
tially also as a treatment for stabilization of ectasia.
Disclosure
This research was presented in part at the 15th Winter 
Meeting of the European Society of Cataract and Refractive 
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
651
Novel refractive surgery techniqueClinical Ophthalmology
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/clinical-ophthalmology-journal
Clinical Ophthalmology is an international, peer-reviewed journal 
covering all subspecialties within ophthalmology. Key topics include: 
Optometry; Visual science; Pharmacology and drug therapy in eye 
diseases; Basic Sciences; Primary and Secondary eye care; Patient 
Safety and Quality of Care Improvements. This journal is indexed on 
PubMed Central and CAS, and is the official journal of The Society of 
Clinical Ophthalmology (SCO). The manuscript management system 
is completely online and includes a very quick and fair peer-review 
system, which is all easy to use. Visit http://www.dovepress.com/ 
testimonials.php to read real quotes from published authors.
Clinical Ophthalmology 2012:6
Surgeons, Istanbul, Turkey, February 18–20, 2011. The 
author has served in the past as a nonpaid consultant for 
Seros Medical (Palo Alto, CA) and is a consultant for Alcon/
Wavelight. The novel infrared laser device, technical assis-
tance, and study design advice were generously provided by 
Satish Herakar, cofounder of Seros Medical.
References
  1.  Stringer H, Parr J. Shrinkage temperature of eye collagen. Nature. 
1964;204:1307.
  2.  Thompson VM, Seiler T, Durrie DS, Cavanaugh TB. Holmium:YAG 
laser thermokeratoplasty for hyperopia and astigmatism: an overview. 
Refract Corneal Surg. 1993;9(Suppl 2):S134–S137.
  3.  Geerling G, Koop N, Tüngler A, et al. Diode laser thermokeratoplasty. 
Initial clinical experiences. Ophthalmologe. 1999;96(5):306–311. 
German.
  4.  Bende T, Jean B, Oltrup T. Laser thermal keratoplasty using a continu-
ous wave diode laser. J Refract Surg. 1999;15(2):154–158.
  5.  Ren Q, Simon G, Parel JM. Noncontact laser photothermal   keratoplasty. 
III: Histological study in animal eyes. J Refract Corneal Surg. 
1994;10(5):529–539.
  6.  Parel JM, Ren Q, Simon G. Noncontact laser photothermal keratoplasty. 
I: Biophysical principles and laser beam delivery system. J Refract 
Corneal Surg. 1994;10(5):511–518.
  7.  Ehrlich JS, Manche EE. Regression of effect over long-term follow-up 
of conductive keratoplasty to correct mild to moderate hyperopia. 
J Cataract Refract Surg. 2009;35(9):1591–1596.
  8.  Kato N, Toda I, Kawakita T, Sakai C, Tsubota K. Topography-guided 
conductive keratoplasty: treatment for advanced keratoconus. Am J 
Ophthalmol. 2010;150(4):481–489.
  9.  Kymionis GD, Kontadakis GA, Naoumidi TL, Kazakos DC, Giapitzakis I,   
Pallikaris IG. Conductive keratoplasty followed by collagen cross-
linking with riboflavin-UV-A in patients with keratoconus. Cornea. 
2010;29(2):239–243.
  10.  Horn G, Spears KG, Lopez O, et al. New refractive method for laser 
thermal keratoplasty with the Co: MgF2 laser. J Cataract Refract Surg. 
1990;16(5):611–616.
  11.  Koch DD. Histological changes and wound healing response   following 
noncontact holmium: YAG laser thermal keratoplasty. Trans Am 
  Ophthalmol Soc. 1996;94:745–802.
  12.  Ariyasu RG, Sand B, Menefee R, et al. Holmium laser thermal 
keratoplasty of 10 poorly sighted eyes. J Refract Surg. 1995;11(5): 
358–365.
  13.  Neumann AC, Fyodorov S, Sanders DR. Radial thermokeratoplasty 
for the correction of hyperopia. Refract Corneal Surg. 1990;6(6): 
404–412.
  14.  Hatch JL. Thermal wedge with penetrating keratoplasty to reduce high 
corneal cylinder. Am J Ophthalmol. 1980;90(2):137–141.
  15.  Barsam A, Patmore A, Muller D, Marshall J. Keratorefractive effect of 
microwave keratoplasty on human corneas. J Cataract Refract Surg. 
2010;36(3):472–476.
  16.  Pearce JA, Panescu D. Radiofrequency conductive keratoplasty in the 
cornea: prediction of diopter changes in numerical models. Conf Proc 
IEEE Eng Med Biol Soc. 2004;7:5426–5429.
  17.  Trembly BS, Keates RH. Combined microwave heating and surface 
cooling of the cornea. IEEE Trans Biomed Eng. 1991;38(1):85–91.
  18.  Kanellopoulos AJ. The management of cornea blindness from severe 
corneal scarring, with the Athens protocol (transepithelial topography-
guided PRK therapeutic remodeling, combined with same-day, collagen 
cross-linking). Clin Ophthalmol. 2012;6:87–90.
  19.  Mainster MA. Ophthalmic applications of infrared lasers – thermal 
considerations. Invest Ophthalmol Vis Sci. 1979;18(4):414–420.
  20.  Kanellopoulos AJ. Long term results of a prospective randomized 
  bilateral eye comparison trial of higher fluence, shorter duration 
  ultraviolet A radiation, and riboflavin collagen cross linking for 
  progressive keratoconus. Clin Ophthalmol. 2012;6:97–101.
  21.  Caporossi A, Mazzotta C, Baiocchi S, Caporossi T, Paradiso1 AL. 
  Transepithelial corneal collagen crosslinking for keratoconus: 
  qualitative investigation by in vivo HRT II confocal analysis. Eur J 
Ophthalmol. February 17, 2012. [Epub ahead of print.]
  22.  Kanellopoulos AJ. Post-LASIK ectasia. Ophthalmology. 2007; 
114(6):1230.
  23.  Kanellopoulos AJ, Skouteris VS. Secondary ectasia due to forceps injury 
at childbirth: management with combined topography-guided partial 
PRK and collagen cross-linking (Athens protocol) and subsequent 
phakic IOL implantation. J Refract Surg. 2011;27(9):635–636.
  24.  Kanellopoulos AJ, Binder PS. Management of corneal ectasia 
after LASIK with combined, same-day, topography-guided partial 
  transepithelial PRK and collagen cross-linking: the Athens protocol.   
J Refract Surg. 2011;27(5):323–331.
  25.  Krueger  RR,  Kanellopoulos AJ.  Stability  of  simultaneous 
  topography-guided photorefractive keratectomy and riboflavin/UVA 
cross-linking for progressive keratoconus: case reports. J Refract Surg. 
2010;26(10):S827–832.
  26.  Kanellopoulos AJ. Comparison of sequential vs same-day simultane-
ous collagen cross-linking and topography-guided PRK for treatment 
of keratoconus. J Refract Surg. 2009;25(9):S812–S818.
  27.  Kanellopoulos AJ, Binder PS. Collagen cross-linking (CCL) with 
  sequential topography-guided PRK: a temporizing alternative 
for   keratoconus to penetrating keratoplasty. Cornea. 2007;26(7): 
891–895.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
652
Kanellopoulos